Can a series of blows to the head lead to amyotrophic lateral sclerosis (ALS)? Two studies at Cedars-Sinai have provided some early answers and guidance for future research.
News & Notes
Research at Cedars-Sinai shows cutting off specific nerves to the kidney actually could improve insulin’s effectiveness in the liver and have a positive outcome for diabetic patients.
This timeline traces the research of Stephan Targan, MD, from the seed of a great idea to tangible advancements in the treatment of inflammatory bowel disease (IBD).
Eighteen patients are about to receive an investigational stem cell/gene therapy combination that may stall progression of amyotrophic lateral sclerosis (ALS).
Cardiologists at Cedars-Sinai have modified a tried-and-true surgical procedure to successfully treat the most common heart problem among extremely premature babies, patent ductus arteriosus (PDA).
Military veterans will be among the first patients to receive an investigational therapy for a condition called heart failure with preserved ejection fraction.
Cedars-Sinai investigators have discovered that an enzyme associated with energy production also plays a key role in boosting immunity to disease.
Michael Freeman, PhD, and Sungyong You, PhD, are finding ways to identify which patients are likely to develop aggressive types of prostate cancer even if their tumors at first appear to be lower risk.